Outpatient Surgery Magazine

The Art of the IV Start - December 2014 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/430472

Contents of this Issue

Navigation

Page 23 of 141

2 4 O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E | D E C E M B E R 2 0 1 4 C ould an alternative to propofol be on its way? Drawbridge Pharmaceuticals, an Australian company, hopes to bring an anesthetic called Phaxan to market in the next few years. The brand is new, but the fundamental science behind the new drug isn't. Phaxan is a reformulation of a once-popular, but long- gone, anesthetic called Althesin. "Althesin was a very well-loved drug that was marketed by Glaxo everywhere except the United States between 1972 and 1984," says anesthesiologist and surgeon Colin Goodchild, PhD, Drawbridge's co-director and chief medical officer. "It still has the highest safety profile of any anesthetic that's ever been synthe- sized." SURGEONS' Lounge THE : Will Phaxan Challenge Propofol's Dominance? Drawbridge Pharmaceuticals ALTHESIN REBIRTH Drawbridge Pharmaceuticals says Phaxan has a much higher safety profile than propofol. A SAFER ANESTHETIC

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - The Art of the IV Start - December 2014 - Subscribe to Outpatient Surgery Magazine